Sort   by:  
 Page size 
UnknownPeriod-Dependent Survival Benefit of Percutaneous Microwave Ablation for Hepatocellular Carcinoma: A 12-Year Real-World, Multicentric Experience.
Not available
S-EPMC9294937 | biostudies-literature
UnknownThe impact on incident tuberculosis by kidney function impairment status: analysis of severity relationship.
Not available
S-EPMC7017479 | biostudies-literature
UnknownStudy of Malformin C, a Fungal Source Cyclic Pentapeptide, as an Anti-Cancer Drug.
Not available
S-EPMC4635020 | biostudies-literature
UnknownThe crescent-like Golgi ribbon is shaped by the Ajuba/PRMT5/Aurora-A complex-modified HURP.
Not available
S-EPMC10294536 | biostudies-literature
UnknownContrast-Enhanced Ultrasound Liver Imaging Reporting and Data System in Hepatocellular Carcinoma ≤5 cm: Biological Characteristics and Patient Outcomes.
Not available
S-EPMC10561321 | biostudies-literature
UnknownCigarette smoke-induced LKB1/AMPK pathway deficiency reduces EGFR TKI sensitivity in NSCLC.
Not available
S-EPMC7878190 | biostudies-literature
UnknownTaPPR13, a Pentatricopeptide Repeat Protein Gene Activated by TaBZR2, Confers Drought Stress Tolerance by Enhancing the Antioxidant Defense System and Promoting Retrograde Signaling in Wheat (Triticum aestivum).
Not available
S-EPMC12462999 | biostudies-literature
UnknownEpigenome-wide association study on asthma and chronic obstructive pulmonary disease overlap reveals aberrant DNA methylations related to clinical phenotypes.
Not available
S-EPMC7930096 | biostudies-literature
UnknownGefitinib Versus Vinorelbine Plus Cisplatin as Adjuvant Treatment for Stage II-IIIA (N1-N2) EGFR-Mutant NSCLC: Final Overall Survival Analysis of CTONG1104 Phase III Trial.
Not available
S-EPMC8078324 | biostudies-literature
UnknownGenomic signatures define three subtypes of EGFR-mutant stage II-III non-small-cell lung cancer with distinct adjuvant therapy outcomes.
Not available
S-EPMC8575965 | biostudies-literature
Sort   by:  
 Page size